Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALNY
RMD
Add up to 3 more stocks
ALNY
Alnylam Pharmaceuticals, Inc.
-1.70%
$241.34-4.17Delayed quote: Sep 18, 2026, 3:05 PM EDT
Market Cap
$32.29B
52W Range
$197.81 - $495.55
RMD
ResMed Inc.
-0.70%
$226.82-1.59Delayed quote: Sep 18, 2026, 3:00 PM EDT
Market Cap
$32.90B
52W Range
$180.27 - $284.87
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 40.77 | 21.81 |
| Forward P/E | 36.16 | 18.75 |
| P/B Ratio | 23.85 | 5.00 |
| P/S Ratio | 6.72 | 5.82 |
| P/FCF Ratio | 59.52 | N/A |
| EV/EBITDA | 30.22 | 15.43 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.7% | 61.2% |
| Operating Margin | 20.8% | 33.5% |
| Net Margin | 16.8% | 26.9% |
| ROE | 59.7% | 23.1% |
| ROA | 14.5% | 17.0% |
| ROIC | 24.7% | 19.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.05 | 3.10 |
| Quick Ratio | 2.99 | 2.42 |
| Debt/Equity | 0.94 | 0.13 |
| Interest Coverage | 1.99 | 65.20 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 1.1% |
| Payout Ratio | N/A | 23.1% |
| Yrs of Dividend Growth | 0 | 13 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.